ARS Pharmaceuticals, Inc. (SPRY)
USD 10.96
(-6.8%)
USD 10.96
(-6.8%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 30 Thousand | 1.31 Million | 5.5 Million | 17.83 Million | - | - |
| Cost of Revenue | 20.06 Million | 17.32 Million | 20.27 Million | 14.07 Million | 1.54 Million | 1.42 Million |
| Gross Profit | -20.03 Million | -16 Million | -14.76 Million | 3.76 Million | -1.54 Million | -1.42 Million |
| Operating Expenses | 67.55 Million | 36.83 Million | 24.96 Million | 18.3 Million | 22.52 Million | 16.9 Million |
| Selling, General and Administrative Expenses | 47.28 Million | 18.45 Million | 4.68 Million | 4.23 Million | 1.01 Million | 2.09 Million |
| Research and Development Expenses | 20.26 Million | 18.37 Million | 20.27 Million | 14.07 Million | 21.5 Million | 14.8 Million |
| Other Expenses | - | 974 Thousand | -789 Thousand | -596 Thousand | - | - |
| Cost and Expenses | 67.55 Million | 36.83 Million | 24.96 Million | 18.3 Million | 24.06 Million | 18.32 Million |
| Operating Income | -67.52 Million | -35.51 Million | -19.45 Million | -469 Thousand | -24.06 Million | -18.32 Million |
| Interest Expense | - | - | 106 Thousand | 29 Thousand | - | - |
| Income Tax Expense | - | -694 Thousand | -230.55 Thousand | -200.29 Thousand | - | - |
| Earnings before Tax | -54.36 Million | -34.68 Million | -20.24 Million | -1.06 Million | -23.96 Million | -17.57 Million |
| Net Income | -54.36 Million | -33.98 Million | -20.24 Million | -1.06 Million | -23.96 Million | -17.57 Million |
| Earnings Per Share Basic | -0.57 | -0.85 | -0.70 | -0.03 | -0.72 | -0.53 |
| Earnings Per Share Diluted | -0.57 | -0.85 | -0.70 | -0.03 | -0.72 | -0.53 |
| Weighted Average Shares Outstanding | 95.21 Million | 39.95 Million | 28.87 Million | 34.7 Million | 33.06 Million | 33.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 95.21 Million | 39.95 Million | 28.87 Million | 34.7 Million | 33.06 Million | 33.06 Million |
| Gross Margin | -667.87 | -12.16 | -2.68 | 0.21 | - | - |
| EBIT Margin | -2248.23 | -26.64 | -3.53 | -0.03 | - | - |
| Profit Margin | -1812.17 | -25.83 | -3.68 | -0.06 | - | - |
| EBITDA | -67.44 Million | -35.51 Million | -19.24 Million | -463 Thousand | -22.52 Million | -16.9 Million |
| Earnings Before Tax Margin | -2250.67 | -26.99 | -3.53 | -0.03 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 500 Thousand | - | 30 Thousand | -30 Thousand | - | 10 Thousand |
| Cost of Revenue | 18 Thousand | 11 Thousand | 73 Thousand | 12 Thousand | 21 Thousand | 7.3 Million |
| Gross Profit | 482 Thousand | -11 Thousand | -43 Thousand | -42 Thousand | -21 Thousand | -7.29 Million |
| Operating Expenses | 15.82 Million | 13.18 Million | 67.47 Million | 10.21 Million | 17.97 Million | 20.61 Million |
| Selling, General and Administrative Expenses | 8.92 Million | 7.94 Million | - | 6.81 Million | 14.97 Million | 13.3 Million |
| Research and Development Expenses | 6.89 Million | 5.23 Million | - | 3.4 Million | 3 Million | 7.3 Million |
| Other Expenses | 2.82 Million | 2.9 Million | 13.15 Million | 3.05 Million | 3.11 Million | 3.23 Million |
| Cost and Expenses | 15.84 Million | 13.19 Million | 67.55 Million | 10.22 Million | 17.97 Million | 20.61 Million |
| Operating Income | -15.34 Million | -13.19 Million | -67.52 Million | -10.22 Million | -17.97 Million | -20.6 Million |
| Interest Expense | - | - | - | 3.75 Million | - | - |
| Income Tax Expense | - | -32.27 Thousand | -94.89 Thousand | 3.81 Million | -40 Thousand | -20 Thousand |
| Earnings before Tax | -12.51 Million | -10.29 Million | -54.36 Million | -7.16 Million | -14.84 Million | -17.37 Million |
| Net Income | -12.51 Million | -10.29 Million | -54.36 Million | -7.16 Million | -14.84 Million | -17.37 Million |
| Earnings Per Share Basic | -0.13 | -0.11 | - | -0.07 | -0.16 | -0.18 |
| Earnings Per Share Diluted | -0.13 | -0.11 | - | -0.07 | -0.16 | -0.18 |
| Weighted Average Shares Outstanding | 96.82 Million | 96.48 Million | 95.21 Million | 96.41 Million | 95.57 Million | 94.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 96.82 Million | 96.48 Million | 95.21 Million | 96.41 Million | 95.57 Million | 94.91 Million |
| Gross Margin | 0.96 | - | -1.43 | 1.40 | - | -729.80 |
| EBIT Margin | -30.64 | - | - | 340.47 | - | -2060.30 |
| Profit Margin | -25.03 | - | -1812.17 | 238.93 | - | -1737.00 |
| EBITDA | -15.32 Million | -13.18 Million | - | -10.21 Million | -17.99 Million | -20.6 Million |
| Earnings Before Tax Margin | -30.68 | - | -2250.67 | 340.87 | - | -2060.30 |
MAP
AFFY
ROVR
CUII
WHN
MODIRUBBER